uu.seUppsala universitets publikasjoner
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Clinical validation of the HPVIR high-risk HPV test on cervical samples according to the international guidelines for human papillomavirus DNA test requirements for cervical cancer screening
Uppsala universitet, Science for Life Laboratory, SciLifeLab. Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Medicinska fakulteten, Institutionen för immunologi, genetik och patologi, Medicinsk genetik och genomik.
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Medicinska fakulteten, Institutionen för kvinnors och barns hälsa, Forskargrupper (Inst. för kvinnor och barns hälsa), Reproduktionsbiologi.
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Medicinska fakulteten, Institutionen för kvinnors och barns hälsa, Forskargrupper (Inst. för kvinnor och barns hälsa), Reproduktionsbiologi. Uppsala Univ, Dept Womens & Childrens Hlth, SE-75185 Uppsala, Sweden.
Uppsala universitet, Science for Life Laboratory, SciLifeLab. Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Medicinska fakulteten, Institutionen för immunologi, genetik och patologi, Medicinsk genetik och genomik.
Vise andre og tillknytning
2019 (engelsk)Inngår i: Virology Journal, ISSN 1743-422X, E-ISSN 1743-422X, Vol. 16, nr 1, artikkel-id 107Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Background

The indicating FTA card is a dry medium used for collection of cervical samples. HPVIR is a multiplex real-time PCR test that detects 12 high-risk human papillomavirus types (hrHPV) and provides single genotype information for HPV16, − 31, − 35, − 39, − 51, − 56, and − 59 and pooled type information for HPV18/45 and HPV33/52/58. The aim of this study was to evaluate whether a strategy with cervical samples collected on the FTA card and subsequently analysed with the HPVIR test complies with the criteria of the international guidelines for a clinically validated method for cervical screening.

Methods

We performed a non-inferiority test comparing the clinical sensitivity and specificity of the candidate test (FTA card and HPVIR) with a clinically validated reference test (Cobas® HPV test) based on liquid-based cytology (LBC) samples. Two clinical samples (LBC and FTA) were collected from 896 participants in population-based screening. For evaluation of the specificity we used 799 women without ≥ CIN2, and for clinical sensitivity we used 67 women with histologically confirmed ≥ CIN2. The reproducibility was studied by performing inter- and intra-laboratory tests of 558 additional clinical samples.

Results

The clinical sensitivity and specificity for samples collected on the FTA card and analysed using the HPVIR test were non-inferior to samples analysed with the Cobas® HPV test based on LBC samples (non-inferiority test score, p = 1.0 × 10− 2 and p = 1.89 × 10− 9, respectively). Adequate agreement of > 87% was seen in both the intra- and inter-laboratory comparisons.

Conclusions

Samples collected on the indicating FTA card and analysed with HPVIR test fulfil the requirements of the international guidelines and can therefore be used in primary cervical cancer screening.

sted, utgiver, år, opplag, sider
2019. Vol. 16, nr 1, artikkel-id 107
Emneord [en]
HPV, DNA testing, Primary cervical cancer screening, International guidelines
HSV kategori
Identifikatorer
URN: urn:nbn:se:uu:diva-394268DOI: 10.1186/s12985-019-1216-7ISI: 000483382500001PubMedID: 31438976OAI: oai:DiVA.org:uu-394268DiVA, id: diva2:1359407
Forskningsfinansiär
Forte, Swedish Research Council for Health, Working Life and WelfareSwedish Cancer SocietyTilgjengelig fra: 2019-10-09 Laget: 2019-10-09 Sist oppdatert: 2019-10-09bibliografisk kontrollert

Open Access i DiVA

fulltekst(580 kB)59 nedlastinger
Filinformasjon
Fil FULLTEXT01.pdfFilstørrelse 580 kBChecksum SHA-512
3c2ec3f41e9c80bfde6f8ea9d325a58e3f4e1a48b4bf856c2959db43b64d99cef120c252fd73091698d92ca2cb87bf44cec8cbca2b5f3be305a9f3f190214997
Type fulltextMimetype application/pdf

Andre lenker

Forlagets fulltekstPubMed

Personposter BETA

Gustavsson, Inger M.Aarnio, RiinaLindberg, Julia HedlundWikström, IngridEnroth, StefanOlovsson, MattsGyllensten, Ulf B.

Søk i DiVA

Av forfatter/redaktør
Gustavsson, Inger M.Aarnio, RiinaLindberg, Julia HedlundWikström, IngridEnroth, StefanOlovsson, MattsGyllensten, Ulf B.
Av organisasjonen
I samme tidsskrift
Virology Journal

Søk utenfor DiVA

GoogleGoogle Scholar
Totalt: 59 nedlastinger
Antall nedlastinger er summen av alle nedlastinger av alle fulltekster. Det kan for eksempel være tidligere versjoner som er ikke lenger tilgjengelige

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 83 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf